In 2023, Mexico and South Africa recorded the highest mortality rates from endocrine, nutritional, and metabolic diseases among females, surpassing 200 and 170 deaths per 100,000 women, respectively. Eastern European countries like Croatia also reported significant rates, while many Western nations such as Belgium, Netherlands, and the UK showed lower figures. Notably, Japan and Iceland exhibited some of the lowest rates, under 15. Year-on-year variations indicate notable increases in Estonia and Costa Rica, whereas Portugal, Greece, and Slovakia experienced declines. The average variation over the last five years highlights a sharp increase in Estonia and a general stabilization in Western countries.
Future trends to watch include the impact of health policies targeting lifestyle diseases, evolving healthcare systems in developing regions, and the influence of socioeconomic factors on mortality rates. Critical emerging markets may experience shifts due to improved healthcare access and nutritional education, while developed nations may focus on mitigating lifestyle-related conditions, potentially stabilizing mortality rates further.
Top countries in Endocrine, Nutritional and Metabolic Diseases Mortality by Country
| # | 10 Countries | Units (Female Deaths) Per Hundred Thousand Women, Standardised Rates | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Mexico | 204.6 | 2023 | +0.29% | +3.48% | View data |
| 2 | 2 South Africa | 173.6 | 2023 | +0.46% | +0.63% | View data |
| 3 | 3 Croatia | 119.3 | 2023 | +9.55% | +15.06% | View data |
| 4 | 4 Brazil | 77.9 | 2023 | +0.26% | +3.5% | View data |
| 5 | 5 Costa Rica | 70.9 | 2023 | 0% | +10.31% | View data |
| 6 | 6 Peru | 57.7 | 2023 | -0.17% | +3.88% | View data |
| 7 | 7 Colombia | 54.7 | 2023 | -0.18% | +7.56% | View data |
| 8 | 8 United States | 47.6 | 2023 | +3.7% | +6.16% | View data |
| 9 | 9 Israel | 43.8 | 2023 | +0.46% | -0.49% | View data |
| 10 | 10 Austria | 35.3 | 2023 | 0% | +1.86% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...